X0609 4 2026-06-02 false 0002044725 Evommune, Inc. EVMN 0001347383 Cohen David E false C/O EVOMMUNE, INC. 1891 PAGE MILL ROAD PALO ALTO CA 94304 true false false false true Common Stock 2026-06-02 4 S false 5456.00 20.21 D 18209.00 D Common Stock 2026-06-02 4 S false 600.00 21.38 D 17609.00 D Stock Option (Right to buy) 19.82 2026-06-02 4 A false 15673.00 0.00 A 2036-06-01 Common Stock 15673.00 15673.00 D The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $20.00 to $20.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $21.06 to $21.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. The shares subject to the option award shall vest at the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date. /s/ Gregory S. Moss, Attorney-in-Fact 2026-06-03